Ines Mader, Patrizia R. Fürst-Weger, Robert M. Mader, Elisabeth Nogler-Semenitz, Sabine Wassertheurer
Extravasation of Cytotoxic Agents (eBook, PDF)
Compendium for Prevention and Management
96,29 €
inkl. MwSt.
Sofort per Download lieferbar
Ines Mader, Patrizia R. Fürst-Weger, Robert M. Mader, Elisabeth Nogler-Semenitz, Sabine Wassertheurer
Extravasation of Cytotoxic Agents (eBook, PDF)
Compendium for Prevention and Management
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
The extravasation of cytotoxic agents can result in severe local tissue damage and medical emergencies during tumour therapy. This revised compendium is intended to help clinicians assess any situation speedily and with certainty. The general section of the book includes topics such as predisposition, prevention, type of harm, general measures in handling extravasated drugs, specific antidotes, and documentation. In the 2nd edition, the scientific information contained in the general section and relating to the actual substances has been updated. The substance specific part of the book…mehr
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 4.55MB
- Upload möglich
Andere Kunden interessierten sich auch für
- Management of Chemotherapy-Induced Nausea and Vomiting (eBook, PDF)53,49 €
- Ines MaderParavasation von Zytostatika (eBook, PDF)53,94 €
- In Vivo Imaging of Cancer Therapy (eBook, PDF)106,99 €
- Pancreatic Cancer (eBook, PDF)142,95 €
- Terrence PriestmanCancer Chemotherapy in Clinical Practice (eBook, PDF)53,49 €
- Hepatocellular Carcinoma (eBook, PDF)106,99 €
- Induction Chemotherapy (eBook, PDF)106,99 €
-
-
-
The extravasation of cytotoxic agents can result in severe local tissue damage and medical emergencies during tumour therapy. This revised compendium is intended to help clinicians assess any situation speedily and with certainty. The general section of the book includes topics such as predisposition, prevention, type of harm, general measures in handling extravasated drugs, specific antidotes, and documentation. In the 2nd edition, the scientific information contained in the general section and relating to the actual substances has been updated. The substance specific part of the book includes detailed instructions on handling more than 50 cytotoxic drugs, to initiate targeted measures. Templates for an extravasation set, overview tables, documentation sheets, and patient information, as we as a CD-ROM are included to support clinical practice. The book is the outcome of a consensus of an interdisciplinary working group that has collected and systematically reviewed all published literature on the topic.
Produktdetails
- Produktdetails
- Verlag: Springer Wien
- Erscheinungstermin: 2. Dezember 2009
- Englisch
- ISBN-13: 9783211888933
- Artikelnr.: 37358628
- Verlag: Springer Wien
- Erscheinungstermin: 2. Dezember 2009
- Englisch
- ISBN-13: 9783211888933
- Artikelnr.: 37358628
Problem outline Literature search methods General partIntroduction and definitions (Robert Mader) Incidence of extravasations Definition Type of damage Potential damage mechanisms Damage mechanisms of the anthracyclines Necrosis potential of individual cytotoxic agents Predisposition and prevention (Ines Mader) Risk factors Risk factors associated with patients Medication-related risk factors Iatrogenic risk factors Risk factors associated with central venouscatheter systems Prevention Patient education/information Clinical practice (Ines Mader) Peripheral venous extravasations Central venous extravasations Histopathological investigations Differential diagnosis Thrombophlebitides Cutaneous hypersensitivity reactions Systemic hypersensitivity reactions Recall phenomena Photosensitivity Measures (Robert Mader) General unspecific measures in peripheral venous access General unspecific measures in central venous access Specific measures/antidotes Topical cooling Dry heat Dimethylsulfoxide (DMSO) Hyaluronidase Dexrazoxane 5-Fluorouracil (Sabine Wassertheurer) Fotemustine (Patrizia Fürst-Weger) Gemcitabine (Sabine Wassertheurer) Idarubicin (Elisabeth Nogler-Semenitz) Ifosfamide (Patrizia Fürst-Weger) Irinotecan (Ines Mader) Melphalan (Patrizia Fürst-Weger) Methotrexate (Sabine Wassertheurer) Mitomycin C (Elisabeth Nogler-Semenitz) Mitoxantrone (Elisbeth Nogler-Semenitz) Nimustine (Patrizia Fürst-Weger) Oxaliplatin (Patrizia Fürst-Weger) Paclitaxel (Ines Mader) Pegaspargase (Patrizia Fürst-Weger) Pemetrexed (Sabine Wassertheurer) Pentostatin (Sabine Wassertheurer) Raltitrexed (Sabine Wassertheurer) Streptozocin (Patrizia Fürst-Weger) Teniposide (Ines Mader) Thiotepa (Patrizia Fürst-Weger) Topotecan (Ines Mader) Treosulfan (PatriziaFürst-Weger Trimetrexate (Sabine Wassertheurer) Vinblastine (Ines Mader) Vincristine (Ines Mader) Vindesine (Ines Mader) Vinorelbine (Ines Mader) Subject Index
Problem outlineLiterature search methodsGeneral partIntroduction and definitions (Robert Mader)Incidence of extravasationsDefinitionType of damagePotential damage mechanismsDamage mechanisms of the anthracyclinesNecrosis potential of individual cytotoxic agentsPredisposition and prevention (Ines Mader)Risk factorsRisk factors associated with patientsMedication-related risk factorsIatrogenic risk factorsRisk factors associated with central venouscatheter systems PreventionPatient education/informationClinical practice (Ines Mader)Peripheral venous extravasationsCentral venous extravasationsHistopathological investigationsDifferential diagnosisThrombophlebitidesCutaneous hypersensitivity reactionsSystemic hypersensitivity reactionsRecall phenomenaPhotosensitivityMeasures (Robert Mader)General unspecific measures in peripheral venous accessGeneral unspecific measures in central venous accessSpecific measures/antidotesTopical coolingDry heatDimethylsulfoxide (DMSO)HyaluronidaseDexrazoxane5-Fluorouracil (Sabine Wassertheurer)Fotemustine (Patrizia Fürst-Weger)Gemcitabine (Sabine Wassertheurer)Idarubicin (Elisabeth Nogler-Semenitz)Ifosfamide (Patrizia Fürst-Weger)Irinotecan (Ines Mader)Melphalan (Patrizia Fürst-Weger)Methotrexate (Sabine Wassertheurer)Mitomycin C (Elisabeth Nogler-Semenitz)Mitoxantrone (Elisbeth Nogler-Semenitz)Nimustine (Patrizia Fürst-Weger)Oxaliplatin (Patrizia Fürst-Weger)Paclitaxel (Ines Mader)Pegaspargase (Patrizia Fürst-Weger)Pemetrexed (Sabine Wassertheurer)Pentostatin (Sabine Wassertheurer)Raltitrexed (Sabine Wassertheurer)Streptozocin (Patrizia Fürst-Weger)Teniposide (Ines Mader)Thiotepa (Patrizia Fürst-Weger)Topotecan (Ines Mader)Treosulfan (PatriziaFürst-WegerTrimetrexate (Sabine Wassertheurer)Vinblastine (Ines Mader)Vincristine (Ines Mader)Vindesine (Ines Mader)Vinorelbine (Ines Mader)Subject Index
Problem outline Literature search methods General partIntroduction and definitions (Robert Mader) Incidence of extravasations Definition Type of damage Potential damage mechanisms Damage mechanisms of the anthracyclines Necrosis potential of individual cytotoxic agents Predisposition and prevention (Ines Mader) Risk factors Risk factors associated with patients Medication-related risk factors Iatrogenic risk factors Risk factors associated with central venouscatheter systems Prevention Patient education/information Clinical practice (Ines Mader) Peripheral venous extravasations Central venous extravasations Histopathological investigations Differential diagnosis Thrombophlebitides Cutaneous hypersensitivity reactions Systemic hypersensitivity reactions Recall phenomena Photosensitivity Measures (Robert Mader) General unspecific measures in peripheral venous access General unspecific measures in central venous access Specific measures/antidotes Topical cooling Dry heat Dimethylsulfoxide (DMSO) Hyaluronidase Dexrazoxane 5-Fluorouracil (Sabine Wassertheurer) Fotemustine (Patrizia Fürst-Weger) Gemcitabine (Sabine Wassertheurer) Idarubicin (Elisabeth Nogler-Semenitz) Ifosfamide (Patrizia Fürst-Weger) Irinotecan (Ines Mader) Melphalan (Patrizia Fürst-Weger) Methotrexate (Sabine Wassertheurer) Mitomycin C (Elisabeth Nogler-Semenitz) Mitoxantrone (Elisbeth Nogler-Semenitz) Nimustine (Patrizia Fürst-Weger) Oxaliplatin (Patrizia Fürst-Weger) Paclitaxel (Ines Mader) Pegaspargase (Patrizia Fürst-Weger) Pemetrexed (Sabine Wassertheurer) Pentostatin (Sabine Wassertheurer) Raltitrexed (Sabine Wassertheurer) Streptozocin (Patrizia Fürst-Weger) Teniposide (Ines Mader) Thiotepa (Patrizia Fürst-Weger) Topotecan (Ines Mader) Treosulfan (PatriziaFürst-Weger Trimetrexate (Sabine Wassertheurer) Vinblastine (Ines Mader) Vincristine (Ines Mader) Vindesine (Ines Mader) Vinorelbine (Ines Mader) Subject Index
Problem outlineLiterature search methodsGeneral partIntroduction and definitions (Robert Mader)Incidence of extravasationsDefinitionType of damagePotential damage mechanismsDamage mechanisms of the anthracyclinesNecrosis potential of individual cytotoxic agentsPredisposition and prevention (Ines Mader)Risk factorsRisk factors associated with patientsMedication-related risk factorsIatrogenic risk factorsRisk factors associated with central venouscatheter systems PreventionPatient education/informationClinical practice (Ines Mader)Peripheral venous extravasationsCentral venous extravasationsHistopathological investigationsDifferential diagnosisThrombophlebitidesCutaneous hypersensitivity reactionsSystemic hypersensitivity reactionsRecall phenomenaPhotosensitivityMeasures (Robert Mader)General unspecific measures in peripheral venous accessGeneral unspecific measures in central venous accessSpecific measures/antidotesTopical coolingDry heatDimethylsulfoxide (DMSO)HyaluronidaseDexrazoxane5-Fluorouracil (Sabine Wassertheurer)Fotemustine (Patrizia Fürst-Weger)Gemcitabine (Sabine Wassertheurer)Idarubicin (Elisabeth Nogler-Semenitz)Ifosfamide (Patrizia Fürst-Weger)Irinotecan (Ines Mader)Melphalan (Patrizia Fürst-Weger)Methotrexate (Sabine Wassertheurer)Mitomycin C (Elisabeth Nogler-Semenitz)Mitoxantrone (Elisbeth Nogler-Semenitz)Nimustine (Patrizia Fürst-Weger)Oxaliplatin (Patrizia Fürst-Weger)Paclitaxel (Ines Mader)Pegaspargase (Patrizia Fürst-Weger)Pemetrexed (Sabine Wassertheurer)Pentostatin (Sabine Wassertheurer)Raltitrexed (Sabine Wassertheurer)Streptozocin (Patrizia Fürst-Weger)Teniposide (Ines Mader)Thiotepa (Patrizia Fürst-Weger)Topotecan (Ines Mader)Treosulfan (PatriziaFürst-WegerTrimetrexate (Sabine Wassertheurer)Vinblastine (Ines Mader)Vincristine (Ines Mader)Vindesine (Ines Mader)Vinorelbine (Ines Mader)Subject Index